Daniela Bartoletti

15PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical virologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 01, 2022
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.

Francesca Palandri, Daniela Bartoletti, Alessandra Iurlo

|Dec 23, 2021
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies.

Francesca Palandri, Christian Di Pietro, Francesca Ricci

|Apr 23, 2021
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.

Francesca Palandri, Elena Rossi, Daniela Bartoletti

|Apr 01, 2021
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.

Francesca Palandri, Mario Tiribelli, Massimo Breccia

|Feb 16, 2021
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.

Giulia Benevolo, Elena M Elli, Daniela Bartoletti

|Nov 22, 2020
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.

Nicola Polverelli, Elena M Elli, Elisabetta Abruzzese

Pageof 3

Frequent Collaborators

10 joint publications

Francesca Palandri

8 joint publications

Massimo Breccia

7 joint publications

Nicola Polverelli

6 joint publications

Mario Tiribelli